Efficacy and Safety of eradication therapy to exterminate Hp

Efficacy and Safety of eradication therapy to exterminate Hp - Hp eradtiocn 3rd line therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011606

Enrollment

Registered

2013-08-30

Start date

2013-09-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patinets with Hp infection

Interventions

STFX+AMPC+PPI If the resistance of STFX is observed, large quantities of AMPC+PPI

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hp infection

Exclusion criteria

Exclusion criteria: The allergy for STFX, AMPC, PPI The physicians decided

Design outcomes

Primary

Measure	Time frame
success rate of Hp eradication	—

Countries

Japan

Contacts

Public ContactMakoto Arai

Chiba University Hospital Gastroenterology

araim-cib@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026